# Outcome Following Truncation of Asparaginase

> **NCT03987542** · — · COMPLETED · sponsor: **Birgitte Klug Albertsen** · enrollment: 1401 (actual)

## Conditions studied

- Relapse Leukemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03987542
- **Lead sponsor:** Birgitte Klug Albertsen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 1401 (ACTUAL)
- **Last updated:** 2022-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03987542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03987542, "Outcome Following Truncation of Asparaginase". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03987542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*